Aging and clinical pharmacology: implications for antidepressants.
about
Going beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical reviewDopaminergic and serotonergic drug use: a nationwide register-based study of over 1,300,000 older peoplePilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.Improving antidepressant adherence and depression outcomes in primary care: the treatment initiation and participation (TIP) program.Between Scylla and Charybdis: antipsychotic and other psychotropic medications in older nursing home residentsMental Health Care Delivered to Younger and Older Adults by Office-Based Physicians NationallySerotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patientsAntidepressant use and cognitive functioning in older medical patients with major or minor depression: a prospective cohort study with database linkage.Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population.A Review of Brain Stimulation Treatments for Late-Life Depression.Brain stimulation in the treatment of late-life severe mental illness other than unipolar nonpsychotic depression.Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety.Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure.Antidepressant adherence and risk of coronary artery disease hospitalizations in older and younger adults with depression.Adherence to Depression Treatment in Primary Care: A Randomized Clinical Trial.Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey.Neural correlates of treatment outcome in major depression.Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder
P2860
Q27022958-8C76FB6A-21CD-4943-B4C4-A582DA75F5F1Q28476572-709C2D2D-0D57-4A01-93CE-42B43CA4ED89Q33917532-6DFB5965-CE28-40E3-99B9-8290562EC97EQ34575130-35CBD149-B300-4D29-A94B-5DDDF7ECF9EEQ34828456-72FD2094-D599-41C0-9AE4-D7441A27793CQ35875587-3BABFCC9-EDE6-4F0B-A2CA-90C546F74B90Q36491587-0D92A99C-19B3-456F-BB27-145A97E5552EQ36573742-2DEFDC9F-415E-4EE7-B2BD-7A8DE9B1662CQ36718601-FB90E89B-1D82-4360-B4F9-29A44E701A83Q37078250-E5834C80-CD5A-4CE4-AEBE-30C20492BF51Q37510360-A2247FA6-4D14-419F-AB7C-4A7694B604C7Q38367401-34542914-226C-4D53-9806-4B0EAA8A2E26Q39317953-4E886D48-3830-4194-80AD-8AB11A173174Q43435841-D8FC4176-E7EC-4E62-AF14-6AF88FF7CCE9Q47751182-BD47D063-144A-4A0E-B771-5F521C1A806DQ48372273-419B6EE9-3D81-4BAD-8AB1-D6A4A53F00C4Q48934472-37B7148E-A7DC-43EE-8857-3640B18DDFF9Q55396723-00C961BF-3721-446B-993B-B1BE31CD2AF2Q58567918-51C4AC35-0C1F-4B73-8ABF-522F03524EEC
P2860
Aging and clinical pharmacology: implications for antidepressants.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Aging and clinical pharmacology: implications for antidepressants.
@ast
Aging and clinical pharmacology: implications for antidepressants.
@en
type
label
Aging and clinical pharmacology: implications for antidepressants.
@ast
Aging and clinical pharmacology: implications for antidepressants.
@en
prefLabel
Aging and clinical pharmacology: implications for antidepressants.
@ast
Aging and clinical pharmacology: implications for antidepressants.
@en
P2860
P356
P1476
Aging and clinical pharmacology: implications for antidepressants.
@en
P2093
Bruce G Pollock
Francis E Lotrich
P2860
P304
P356
10.1177/0091270005280297
P577
2005-10-01T00:00:00Z